ALZAMEND NEURO INC (ALZN) Stock News

NASDAQ:ALZN - US02262M5067 - Common Stock

2.44 USD

+0.01 (+0.41%)

Last: 8/29/2025, 8:06:13 PM

2.42 USD

-0.02 (-0.82%)

After Hours: 8/29/2025, 8:06:13 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ALZN Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: Benzinga - Mentions: INSM ADI GES LOW ...

Hewlett Packard Enterprise To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday

a month ago - By: Alzamend Neuro, Inc.

Alzamend Neuro to Present at the 2025 Military Health System Research Symposium

a month ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

a month ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

3 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule

3 months ago - By: Benzinga - Mentions: HBIO SPRO RGC BLRX ...

12 Health Care Stocks Moving In Friday's Intraday Session

3 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

4 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

4 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

4 months ago - By: Yahoo Finance - Mentions: PCLN BKNG EXPE PUBM ...

Booking CFO leans on AI in push to run ‘tight ship’

4 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

5 months ago - By: Yahoo Finance - Mentions: GRPN BKNG INTZ

Why Nintendo Stock Is Jumping Today

5 months ago - By: Yahoo Finance - Mentions: COMP

Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March?

5 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

5 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

6 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

6 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

6 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

6 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

6 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

6 months ago - By: Alzamend Neuro, Inc.

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital